Xencor
Latest round
- Series A
Last raised
- Jun 2013
Total raised
- $68M
Investors
- 7
About Xencor
Xencor, Inc.Founded in 1997 in Monrovia, US, Xencor, Inc. engages in the development of antibody therapeutics.50 per share.Xencor specializes in the engineering of antibody therapeutics through its proprietary XmAb® protein engineering platform. The company's core product offerings include a portfolio of bispecific antibodies designed to engage multiple disease targets, thereby enhancing therapeutic efficacy and patient outcomes in oncology and other serious diseases. The XmAb-engineered Fc domains facilitate the development of highly selective immune modulators and targeted cancer therapies, which have shown potential in treating various malignancies.52 mn. Revenue generation primarily stems from strategic collaborations with larger pharmaceutical firms that utilize its innovative antibody technology in their therapeutic development efforts.Xencor plans to continue expanding its product offerings with new drug candidates under the XmAb brand, focusing on upcoming launches that target various malignancies. The ongoing development of its existing pipeline is essential to this strategy. Furthermore, the company aims to penetrate additional markets, particularly targeting Europe and Asia by the end of 2025.
Who invested in Xencor
7 investors across 3 rounds
See all investors in Xencor
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Xencor
Who invested in Xencor?
Xencor has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Xencor raised?
Xencor has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Xencor last raise money?
Xencor's most recent round on record is a Series A, in Jun 2013.
What does Xencor do?
Xencor is a biotechnology company.
Where is Xencor headquartered?
Xencor is headquartered in Monrovia, US.
Which VCs invest in companies like Xencor?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Xencor's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Xencor? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.